chr3-170998041-G-A

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1

The NM_000340.2(SLC2A2):​c.1437C>T​(p.Phe479=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.303 in 1,613,122 control chromosomes in the GnomAD database, including 78,050 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.38 ( 12175 hom., cov: 32)
Exomes 𝑓: 0.30 ( 65875 hom. )

Consequence

SLC2A2
NM_000340.2 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: -0.739
Variant links:
Genes affected
SLC2A2 (HGNC:11006): (solute carrier family 2 member 2) This gene encodes an integral plasma membrane glycoprotein of the liver, islet beta cells, intestine, and kidney epithelium. The encoded protein mediates facilitated bidirectional glucose transport. Because of its low affinity for glucose, it has been suggested as a glucose sensor. Mutations in this gene are associated with susceptibility to diseases, including Fanconi-Bickel syndrome and noninsulin-dependent diabetes mellitus (NIDDM). Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 3-170998041-G-A is Benign according to our data. Variant chr3-170998041-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 130348.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=6}. Variant chr3-170998041-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.739 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.588 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SLC2A2NM_000340.2 linkuse as main transcriptc.1437C>T p.Phe479= synonymous_variant 11/11 ENST00000314251.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SLC2A2ENST00000314251.8 linkuse as main transcriptc.1437C>T p.Phe479= synonymous_variant 11/111 NM_000340.2 P1P11168-1
SLC2A2ENST00000497642.5 linkuse as main transcriptc.*904C>T 3_prime_UTR_variant, NMD_transcript_variant 10/101
ENST00000655926.1 linkuse as main transcriptn.291+3016G>A intron_variant, non_coding_transcript_variant
SLC2A2ENST00000469787.1 linkuse as main transcriptc.*904C>T 3_prime_UTR_variant, NMD_transcript_variant 10/102

Frequencies

GnomAD3 genomes
AF:
0.375
AC:
56935
AN:
151836
Hom.:
12148
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.594
Gnomad AMI
AF:
0.243
Gnomad AMR
AF:
0.341
Gnomad ASJ
AF:
0.329
Gnomad EAS
AF:
0.231
Gnomad SAS
AF:
0.273
Gnomad FIN
AF:
0.244
Gnomad MID
AF:
0.322
Gnomad NFE
AF:
0.292
Gnomad OTH
AF:
0.366
GnomAD3 exomes
AF:
0.307
AC:
76887
AN:
250066
Hom.:
12705
AF XY:
0.304
AC XY:
41164
AN XY:
135376
show subpopulations
Gnomad AFR exome
AF:
0.602
Gnomad AMR exome
AF:
0.285
Gnomad ASJ exome
AF:
0.316
Gnomad EAS exome
AF:
0.235
Gnomad SAS exome
AF:
0.282
Gnomad FIN exome
AF:
0.262
Gnomad NFE exome
AF:
0.299
Gnomad OTH exome
AF:
0.307
GnomAD4 exome
AF:
0.295
AC:
431072
AN:
1461168
Hom.:
65875
Cov.:
37
AF XY:
0.293
AC XY:
213184
AN XY:
726908
show subpopulations
Gnomad4 AFR exome
AF:
0.605
Gnomad4 AMR exome
AF:
0.291
Gnomad4 ASJ exome
AF:
0.317
Gnomad4 EAS exome
AF:
0.223
Gnomad4 SAS exome
AF:
0.279
Gnomad4 FIN exome
AF:
0.263
Gnomad4 NFE exome
AF:
0.289
Gnomad4 OTH exome
AF:
0.318
GnomAD4 genome
AF:
0.375
AC:
57005
AN:
151954
Hom.:
12175
Cov.:
32
AF XY:
0.371
AC XY:
27569
AN XY:
74260
show subpopulations
Gnomad4 AFR
AF:
0.595
Gnomad4 AMR
AF:
0.340
Gnomad4 ASJ
AF:
0.329
Gnomad4 EAS
AF:
0.231
Gnomad4 SAS
AF:
0.273
Gnomad4 FIN
AF:
0.244
Gnomad4 NFE
AF:
0.292
Gnomad4 OTH
AF:
0.364
Alfa
AF:
0.308
Hom.:
17610
Bravo
AF:
0.392
Asia WGS
AF:
0.290
AC:
1012
AN:
3478
EpiCase
AF:
0.301
EpiControl
AF:
0.298

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 21, 2016p.Phe479Phe in exon 11 of SLC2A2: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence, and has been identified in 63.54% (840/1322) of African chromosomes by the 1000 Genomes Project (Phase 3; dbSNP rs5398). -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxDec 04, 2015This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Fanconi-Bickel syndrome Benign:3
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 15, 2021- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Type 2 diabetes mellitus Uncertain:1
Uncertain significance, criteria provided, single submitterresearchClinical Genomics, Uppaluri K&H Personalized Medicine Clinic-Associated with neonatal diabetes, glycogen accumulation in liver leading to hepatomegaly. -
not provided Benign:1
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicOct 22, 2015- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
2.0
DANN
Benign
0.49

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs5398; hg19: chr3-170715830; COSMIC: COSV58587971; COSMIC: COSV58587971; API